Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate for pediatric bronchoscopy sedation
ChiCTR2200065232Phase 4Not yet recruiting
- Sponsor
- Jinan Children's Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in bronchopulmonary diseases (5 arms), sponsored by Jinan Children's Hospital. Primary endpoint: Sedation success rate. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2200065232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065232.